Sunzen Biotech Share Price

Equities

SUNZEN

MYQ0148OO005

Food Processing

End-of-day quote BURSA MALAYSIA 03:30:00 03/05/2024 am IST 5-day change 1st Jan Change
0.34 MYR +1.49% Intraday chart for Sunzen Biotech +6.25% +13.33%

Financials

Sales 2021 90.48M 19.1M 1.59B Sales 2022 97.09M 20.49M 1.71B Capitalization 141M 29.74M 2.48B
Net income 2021 - 0 0 Net income 2022 3M 633K 52.77M EV / Sales 2021 1.49 x
Net cash position 2021 41.96M 8.86M 738M Net cash position 2022 6.98M 1.47M 123M EV / Sales 2022 1.38 x
P/E ratio 2021
227 x
P/E ratio 2022
42.6 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 31.04%
More Fundamentals * Assessed data
Dynamic Chart
Sunzen Biotech Shelves Plans of MYR4.3 Million Stake Acquisition in Farmer International MT
Sunzen Biotech to End Operations of Loss-Making Animal Health Unit MT
Sunzen Biotech Berhad Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Sunzen Biotech Berhad Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Sunzen Biotech Buys MYR4.3 Million Stake in Farmer International MT
Sunzen Biotech Berhad agreed to acquire additional 30% stake in Ecolite Biotech Manufacturing Sdn Bhd from group of sellers for MYR 18.2 million. CI
Sunzen Biotech Berhad Announces Change of Address CI
Sunzen Biotech Berhad Announces Appointment of Puan Aida Lim Binti Abdullah as Independent and Non Executive Member of Audit Committee CI
Sunzen Biotech Berhad Announces Appointment of Aida Lim Binti Abdullah as Independent and Non Executive Member of Nomination Committee CI
Sunzen Biotech Berhad Announces Appointment of Puan Aida Lim Binti Abdullah as Independent and Non Executive Independent Director CI
Sunzen Biotech Berhad Announces Appointment of Aida Lim Binti Abdullah as Independent and Non Executive Member of Remuneration Committee CI
Sunzen Biotech Berhad Announces Change in Financial Year End CI
Sunzen Biotech Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Sunzen Biotech Berhad Announces Resignation of Zeenath Begum Binti Mohamed Mastan as Joint Company Secretary CI
Sunzen Biotech Berhad Appoints Cheng Weng Soon as Joint Company Secretary CI
More news
1 day+1.49%
1 week+6.25%
Current month+3.03%
1 month+1.49%
3 months+19.30%
6 months+41.67%
Current year+13.33%
More quotes
1 week
0.31
Extreme 0.31
0.35
1 month
0.30
Extreme 0.295
0.35
Current year
0.22
Extreme 0.22
0.35
1 year
0.19
Extreme 0.19
0.35
3 years
0.18
Extreme 0.18
0.35
5 years
0.03
Extreme 0.03
0.35
10 years
0.03
Extreme 0.03
0.54
More quotes
Managers TitleAgeSince
Chief Executive Officer 41 16/20/16
Director of Finance/CFO 61 12/08/12
Corporate Secretary - 29/11
Members of the board TitleAgeSince
Director/Board Member 47 01/20/01
Director/Board Member 53 22/14/22
Chief Executive Officer 41 16/20/16
More insiders
Date Price Change Volume
03/24/03 0.34 +1.49% 1 215 000
02/24/02 0.335 +1.52% 3,573,200
30/24/30 0.33 +4.76% 1,436,200
29/24/29 0.315 -1.56% 818,800
26/24/26 0.32 0.00% 576,900

End-of-day quote BURSA MALAYSIA, May 03, 2024

More quotes
Sunzen Biotech Berhad is a Malaysia-based company, which is principally engaged in the businesses of biotechnology research and development, manufacturing and marketing of animal feed supplement products and investment holding. The Company operates through four segments: Manufacturing and trading of animal health products, Trading and processing of crude palm oil and related products, Traditional Chinese medicines and herbal health foods and beverages, and Loan financing. Its products include bird's nest, The Joy of Life collagen drink, Pu Yao Jing tonic, essence of chicken, essence of fish, Pi Pa Gao cough syrup, Bai Foong Wan, food supplements, dried herbs and more. The products are widely distributed to all consumers through retail concept stores in Malaysia as well in Ecolite store online shop. Its subsidiaries include Sunzen Corporation Sdn. Bhd., Sunzen International Sdn. Bhd., Finsource Credit (M) Sdn. Bhd., and Sunzen Lifesciences Sdn. Bhd among others.
More about the company
  1. Stock Market
  2. Equities
  3. SUNZEN Stock